Abstract
This review summarises both the recent and relevant studies about cryptococcal infections in haematologic malignancies and haematopoietic stem cell transplantation. Although uncommon in this patient population, this infection carries a high mortality, especially if left untreated. Given the limited data, we draw some conclusions with respect to management from the solid organ transplantation and HIV-infected literature. Herein, we discuss cryptococcosis with a particular attention to its background, epidemiology, risk factors, clinical presentation, diagnosis, treatment and prevention in this group.
Keywords:
Cryptococcus neoformans; Cryptococcosis; amphotericin B; fluconazole; immune reconstitution.
© 2020 Wiley-VCH GmbH.
MeSH terms
-
AIDS-Related Opportunistic Infections / drug therapy
-
AIDS-Related Opportunistic Infections / microbiology
-
Antifungal Agents / therapeutic use
-
Cryptococcosis* / diagnosis
-
Cryptococcosis* / drug therapy
-
Cryptococcosis* / epidemiology
-
Cryptococcosis* / pathology
-
Cryptococcus gattii / isolation & purification
-
Cryptococcus gattii / pathogenicity
-
Cryptococcus neoformans / isolation & purification
-
Cryptococcus neoformans / pathogenicity
-
HIV Infections / complications
-
Hematologic Neoplasms / complications*
-
Hematopoietic Stem Cell Transplantation / adverse effects*
-
Humans
-
Incidence
-
Meningitis, Cryptococcal / diagnosis
-
Meningitis, Cryptococcal / drug therapy
-
Meningitis, Cryptococcal / epidemiology
-
Meningitis, Cryptococcal / pathology
-
Mortality
-
Risk Factors
-
Virulence